Improving Glycemic Control With Telemedicine and Smart Insulin Pens
Evaluation of a Novel Telemedicine Clinic for Patients With DM2 on Multiple Daily Insulin (MDI) Regimens
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * ≥18 years of age * MDI insulin treated (receiving MDI for at least 3 months prior to the study) Exclusion Criteria: * DM patients not treated with MDI for at least 3 months (i.e diet only, any combination of non-insulin antidiabetic drugs only, basal insulin only or bolus/short acting insulin only) * Patients with DM at the time of screening on insulin pumps * Pregnant patients * Patients with extensive skin disease or allergies that preclude wearing the CGM sensor * Patients who have end-stage renal disease requiring dialysis * Patients with significant psychiatric illness or any other condition rendering the subject incapable of understanding the objectives and potential consequences of the study * Patients who receive hydroxyurea or who are on long (chronic) treatment with acetaminophen * Patients who were started on non-insulin DM medications or had a dose change within 60 days or less prior to study participation * Patient does not have or not able to gain access to a smartphone which is compatible with the necessary applications for DAT
About the study
Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.
What is being tested
- InPen Smart insulin pen (device)
- traditional/standard insulin pen (other)
Sponsor: University of Maryland, Baltimore · Participants: 50 · Started: Jan 30, 2026
Contact the study team
- William Scott, MS · Phone: 4106057000
Official record on ClinicalTrials.gov — NCT06918977
Locations in the U.S.
| Maryland | Baltimore VA Maryland Center, Baltimore VAMHCS, Diabetes Outpatient Clinic, Baltimore (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.